PharmChem, Inc.
PCHMOTCHealthcare
$3.75
+$0.01(+0.27%)
Market Cap$21950509
P/E Ratio—
52W High$3.98
52W Low$2.95
PharmChem, Inc. (PCHM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PCHM · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.09M | $6.01M | $5.84M | $6.22M | $6.67M |
| Cost of Revenue | $2.21M | $2.11M | $2.09M | $2.33M | $2.45M |
| Gross Profit | $3.88M | $3.90M | $3.75M | $3.89M | $4.22M |
| Gross Margin %(computed) | 63.72% | 64.94% | 64.18% | 62.55% | 63.25% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $2.21M | $2.93M | $2.66M | $2.35M | $2.08M |
| Operating Income | $1.66M | $0.97M | $1.08M | $1.54M | $2.14M |
| Operating Margin %(computed) | 27.33% | 16.19% | 18.53% | 24.83% | 32.10% |
| Interest Income | $0.08M | $0.08M | $0.02M | $0.00M | $0.02M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $1.74M | $1.05M | $1.11M | $1.67M | $2.16M |
| Income Tax Expense | $0.36M | $0.21M | $0.24M | ($0.18M) | $0.20M |
| Net Income | $1.38M | $0.85M | $0.87M | $1.85M | $1.96M |
| Net Margin %(computed) | 22.69% | 14.06% | 14.91% | 29.78% | 29.41% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.30 | $0.17 | $0.17 | $0.32 | $0.34 |
| Wtd Avg Shares | 4.65M | 4.97M | 5.07M | 5.77M | 5.85M |
| EBITDA | $1.74M | $1.05M | $1.11M | $1.67M | $2.17M |
| EBITDA Margin %(computed) | 28.61% | 17.53% | 18.95% | 26.90% | 32.48% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more PharmChem, Inc. data
About PharmChem, Inc. (PCHM) Income Statement
PharmChem, Inc. (PCHM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, PCHM reported revenue of $0.01B, gross profit of $0.00B (gross margin 63.72%), and net income of $0.00B — a net profit margin of 22.69%.
Frequently asked questions
PCHM · 4 questionsPharmChem, Inc. (PCHM) reported revenue of $0.01B for 2024, up 1.2% year-over-year.
PCHM revenuePCHM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08